Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31230 | 126 | 33.9 | 82% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD99 | Author keyword | 13 | 27% | 32% | 40 |
2 | CD99 ANTIGEN | Author keyword | 3 | 100% | 2% | 3 |
3 | JL1 | Author keyword | 2 | 50% | 2% | 3 |
4 | UMR 576 | Address | 1 | 27% | 3% | 4 |
5 | HYPERTENS INFLAMMAT | Address | 1 | 40% | 2% | 2 |
6 | CRS DEV BIOMOL THER IES | Address | 1 | 21% | 3% | 4 |
7 | ALLERGY CLIN IMMUNOLCHONGNO GU | Address | 1 | 50% | 1% | 1 |
8 | CD99 PROTEIN | Author keyword | 1 | 50% | 1% | 1 |
9 | CD99L2 | Author keyword | 1 | 50% | 1% | 1 |
10 | EQUIPE HEMATOPOIESE MOL FONCT | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD99 | 13 | 27% | 32% | 40 | Search CD99 | Search CD99 |
2 | CD99 ANTIGEN | 3 | 100% | 2% | 3 | Search CD99+ANTIGEN | Search CD99+ANTIGEN |
3 | JL1 | 2 | 50% | 2% | 3 | Search JL1 | Search JL1 |
4 | CD99 PROTEIN | 1 | 50% | 1% | 1 | Search CD99+PROTEIN | Search CD99+PROTEIN |
5 | CD99L2 | 1 | 50% | 1% | 1 | Search CD99L2 | Search CD99L2 |
6 | FAS AGGREGATION | 1 | 50% | 1% | 1 | Search FAS+AGGREGATION | Search FAS+AGGREGATION |
7 | HBA71 | 1 | 50% | 1% | 1 | Search HBA71 | Search HBA71 |
8 | JL1 ANTIGEN | 1 | 50% | 1% | 1 | Search JL1+ANTIGEN | Search JL1+ANTIGEN |
9 | LYMPHOCYTE RECEPTOR | 1 | 50% | 1% | 1 | Search LYMPHOCYTE+RECEPTOR | Search LYMPHOCYTE+RECEPTOR |
10 | T CELL DIFFERENTIATION ANTIGEN | 1 | 50% | 1% | 1 | Search T+CELL+DIFFERENTIATION+ANTIGEN | Search T+CELL+DIFFERENTIATION+ANTIGEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REED STERNBERG PHENOTYPE | 15 | 82% | 7% | 9 |
2 | MIC2 GENE PRODUCT | 13 | 58% | 12% | 15 |
3 | CD99 ENGAGEMENT | 6 | 80% | 3% | 4 |
4 | E2 MOLECULE | 6 | 100% | 3% | 4 |
5 | MIC2 EXPRESSION | 4 | 25% | 10% | 13 |
6 | PSEUDOAUTOSOMAL GENE | 3 | 30% | 6% | 7 |
7 | MIC2 | 1 | 15% | 7% | 9 |
8 | CD99 MIC2 | 1 | 100% | 2% | 2 |
9 | MONOCLONAL ANTIBODY O 13 | 1 | 50% | 2% | 2 |
10 | EWINGS SARCOMA ANTIGEN | 1 | 40% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells | 2001 | 6 | 46 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UMR 576 | 1 | 27% | 3.2% | 4 |
2 | HYPERTENS INFLAMMAT | 1 | 40% | 1.6% | 2 |
3 | CRS DEV BIOMOL THER IES | 1 | 21% | 3.2% | 4 |
4 | ALLERGY CLIN IMMUNOLCHONGNO GU | 1 | 50% | 0.8% | 1 |
5 | EQUIPE HEMATOPOIESE MOL FONCT | 1 | 50% | 0.8% | 1 |
6 | SCI TECHNOL DEV AGCYBIOMED TECHNOL UN | 1 | 50% | 0.8% | 1 |
7 | SEZ CANCEROL | 1 | 19% | 2.4% | 3 |
8 | PROMETEO | 1 | 17% | 2.4% | 3 |
9 | RICERCA ONCOL | 0 | 20% | 1.6% | 2 |
10 | CATHOLIC HSCT | 0 | 33% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000169437 | EWINGS SARCOMA//EWING SARCOMA//PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR |
2 | 0.0000142231 | U396//HU1D10//UNITE 396 |
3 | 0.0000141297 | PECAM 1//JAM A//JUNCTIONAL ADHESION MOLECULE A |
4 | 0.0000128162 | MIXED GONADAL DYSGENESIS//GONADOBLASTOMA//RING Y CHROMOSOME |
5 | 0.0000114259 | QM GENE//RPL10//QM |
6 | 0.0000112084 | CD43//SIALOPHORIN//LEUKOSIALIN |
7 | 0.0000062956 | T11TS//CD2//CD58 |
8 | 0.0000061553 | HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA |
9 | 0.0000047929 | OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7 |
10 | 0.0000043599 | HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING |